<?xml version="1.0" encoding="UTF-8"?>
<p>To assess the immunogenicity of the bivalent OMVs-H1/RBD preparations, female BALB/c mice were immunized with 5 Âµg/mouse of OMVs-H1/RBD and OMVs-empty in comparison with inactivated H1N1pdm2009 and inactivated MERS-CoV as a positive controls and PBS as a negative control. Mice received a booster dose three weeks after prime immunization (
 <xref ref-type="fig" rid="vaccines-07-00046-f002">Figure 2</xref>a). Sera were collected every two weeks from week two to eight after prime immunization.
</p>
